Bio-Techne Corp (TECH)

Gross profit margin

		Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Gross profit	US$ in thousands	790,272	769,725	769,815	756,496	632,850
Revenue	US$ in thousands	1,219,640	1,159,060	1,136,700	1,105,600	931,032
Gross profit margin		64.80%	66.41%	67.72%	68.42%	67.97%

June 30, 2025 calculation

Gross profit margin = Gross profit ÷ Revenue
= $790,272K ÷ $1,219,640K
= 64.80%

The gross profit margin of Bio-Techne Corp demonstrates a predominantly stable yet gradually declining trend over the analyzed period from June 30, 2021, to June 30, 2025. Specifically, the gross profit margin was 67.97% as of June 30, 2021, and slightly increased to 68.42% by June 30, 2022, indicating a marginal improvement in gross profitability. However, subsequent figures reveal a reversal of this trend, with the margin decreasing to 67.72% by June 30, 2023, and further declining to 66.41% in June 30, 2024. The most recent data point for June 30, 2025, shows a continued downward trend with a gross profit margin of 64.80%.

This pattern suggests that while Bio-Techne maintained a relatively high gross profit margin across the analyzed period, there has been a gradual erosion of gross profitability in recent years. The slight fluctuations initially hint at operational or pricing stability, but the persistent decline in the later years may reflect increased costs of goods sold, pricing pressures, or shifts in product mix impacting the company's ability to sustain prior profit margins. Despite these declines, the margins remain relatively high compared to many industry peers, indicating a potentially strong core profitability but also signifying the need for ongoing analysis to understand the underlying factors contributing to the margin compression.